Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Clinical trial NCT00514085 · COMPLETED
Trial details
- NCT number
- NCT00514085
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-13
- Primary completion
- 2010-09-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.